Navigation Links
Ampio Pharmaceuticals Expands Patent Portfolio of Drugs for Treating Inflammatory Diseases
Date:11/16/2011

GREENWOOD VILLAGE, Colo., Nov. 16, 2011 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NASDAQ: AMPE) ("Ampio" or the "Company"), a company that discovers and develops new uses for previously approved drugs and new molecular entities ("NMEs"), today announced that it has received PTO notification of the allowance of two important U.S. patents. The first patent is directed to a unique class of compounds that combine elements of diketopiperazines (same class as Ampion™) and methylphenidate derivatives. The second patent is directed to novel derivatives of methylphenidate (Ritalin). Both patents contain not only use claims for these novel compounds, and pharmaceutical compositions containing them, but also composition of matter claims.

Dr. David Bar-Or, Chief Science Officer of Ampio, explained, "These novel classes of compounds have demonstrated strong anti-angiogenic activity, anti-proliferative properties in several cancer cell lines, anti-inflammatory activity in various immune activated cell lines (including T cell mediated responses) and other potentially clinically useful responses. The mechanism of action of these compounds is novel and involves, among many findings, the activation of a specific phosphatase, a specific intracellular enzyme."

Dr. Bar-Or further noted, "Lead compounds from each of the two patented classes have been selected, synthesized and tested in-vitro in various human cell lines and are being considered for clinical use for treating Glioblastoma multiforme, a fatal brain cancer, inflammatory breast cancer and for autoimmune/inflammatory conditions, including ophthalmic disorders."

"The company has advanced these compounds to full development status," said Ampio CEO Don Wingerter, "and now that our patent protection is in place, we will begin exploring licensing opportunities for these promising drug candidates."

About Ampi
'/>"/>

SOURCE Ampio Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Ampio Pharmaceuticals Announces Positive Results on Ampion™ Trial for Relief of Nasal Inflammation
2. Champions Oncology, Inc. Appoints Executive Vice President and Chief Financial Officer to Management Team and Corporate Office Relocation
3. Ampio Pharmaceuticals Announces a Proof of Concept Trial of Danazol in the Treatment of Allergic Rhinitis Supports Mechanism of Action of Optina™
4. Ampio Pharmaceuticals Receives Notice of Allowance of its Two Patent Applications on the Combination of Zertane™ with Erectile Dysfunction Drugs in Canada
5. Ampio Announces Positive Results From 12-Week Open Label Extension Study of Zertane™ in Patients With Premature Ejaculation.
6. Champions Oncology Reports Fiscal 2012 First Quarter Financial Results
7. Ampio Pharmaceuticals Executes License and Development Agreement with Daewoong Co. Ltd. to Commercialize Zertane™ in South Korea
8. Ampio Pharmaceuticals Announces Treatment of First Patient in Phase 1b Ampion-In -Knee (AIK) Trial for Osteoarthritis in Australia
9. Ampio Pharmaceuticals, Inc. Releases Results From Phase III Clinical Trial of Zertane™ for the Treatment of Premature Ejaculation (PE), the Most Prevalent Form of Male Sexual Dysfunction
10. Ampio Pharmaceuticals Set to Join Russell 3000 Index
11. Ampio Pharmaceuticals, Inc. Appoints New Independent Director
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... YORK , Sept. 2, 2015 ... is an X-linked disease, which generally affects the ... degeneration and weakness. The disease is caused due ... in the lack of production of dystrophin (a ... individuals. The lack of dystrophin weakens muscle function, ...
(Date:9/2/2015)... NEW YORK , Sept. 2, 2015 ... leukemia is a malignant condition characterized by increased production ... first affects B-lymphocytes and then it can spread to ... mostly at later stages because of the slow buildup ... disease, the malignancy spreads to the spleen, liver, and ...
(Date:9/2/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/l8z67c/pharmaceutical ) has ... China (Basel, Switzerland - November 26-27, 2015)" conference to ... detailed overview of the key areas of pharmaceutical regulatory affairs ... , Macau and ... All important aspects of gaining and maintaining a successful Marketing ...
Breaking Medicine Technology:Global Duchenne Muscular Dystrophy Drugs Market 2015-2019 2Global Duchenne Muscular Dystrophy Drugs Market 2015-2019 3Global Chronic Lymphocytic Leukemia Therapeutics Market 2015-2019 2Global Chronic Lymphocytic Leukemia Therapeutics Market 2015-2019 3Pharmaceutical Regulatory Affairs in China Seminar: Basel, Switzerland - November 26-27, 2015 2
... , SAN FRANCISCO , May 18 ... demonstrated patients treated with a standard or low dose of ... in how often they were awakened at night by hot ... presented today at the 58th Annual Clinical Meeting of the ...
... NANJING , China, May 18 /PRNewswire-Asia/ -- ... ), a leading pharmaceutical company,specializing in the development, manufacturing, and ... preliminary,unaudited financial results for the quarter ended March 31, ... -- Total revenue was RMB458.7 million (US$67.2 million) for ...
Cached Medicine Technology:New Study Shows ENJUVIA® Significantly Reduced 'Sleep Time' Awakenings Caused by Hot Flashes in Postmenopausal Women 2New Study Shows ENJUVIA® Significantly Reduced 'Sleep Time' Awakenings Caused by Hot Flashes in Postmenopausal Women 3New Study Shows ENJUVIA® Significantly Reduced 'Sleep Time' Awakenings Caused by Hot Flashes in Postmenopausal Women 4New Study Shows ENJUVIA® Significantly Reduced 'Sleep Time' Awakenings Caused by Hot Flashes in Postmenopausal Women 5New Study Shows ENJUVIA® Significantly Reduced 'Sleep Time' Awakenings Caused by Hot Flashes in Postmenopausal Women 6New Study Shows ENJUVIA® Significantly Reduced 'Sleep Time' Awakenings Caused by Hot Flashes in Postmenopausal Women 7Simcere Pharmaceutical Group Reports Preliminary Unaudited First Quarter 2010 Results 2Simcere Pharmaceutical Group Reports Preliminary Unaudited First Quarter 2010 Results 3Simcere Pharmaceutical Group Reports Preliminary Unaudited First Quarter 2010 Results 4Simcere Pharmaceutical Group Reports Preliminary Unaudited First Quarter 2010 Results 5Simcere Pharmaceutical Group Reports Preliminary Unaudited First Quarter 2010 Results 6Simcere Pharmaceutical Group Reports Preliminary Unaudited First Quarter 2010 Results 7Simcere Pharmaceutical Group Reports Preliminary Unaudited First Quarter 2010 Results 8Simcere Pharmaceutical Group Reports Preliminary Unaudited First Quarter 2010 Results 9Simcere Pharmaceutical Group Reports Preliminary Unaudited First Quarter 2010 Results 10Simcere Pharmaceutical Group Reports Preliminary Unaudited First Quarter 2010 Results 11Simcere Pharmaceutical Group Reports Preliminary Unaudited First Quarter 2010 Results 12
(Date:9/3/2015)... ... September 03, 2015 , ... At Renew Man™, we ... with the traditional health care model, where the primary care physician dictates and the ... want to become educated about their health issues and empowered to choose their own ...
(Date:9/3/2015)... (PRWEB) , ... September 03, 2015 , ... About 220,800 new cases of prostate cancer ... seven men will be diagnosed with prostate cancer during their lifetime. While only one man ... of every 10 men by age 65, according to the American Cancer Society. ...
(Date:9/3/2015)... ... September 03, 2015 , ... James Earl Jones will be hosting ... this episode, James Earl Jones will introduce a segment that discusses why it is ... how workplace wellness can be fostered in any working environment. , Employers are out ...
(Date:9/3/2015)... FLORIDA (PRWEB) , ... September 03, 2015 , ... ... of the highest-regarded health professionals out there. His perspective on internal medicine keeps patients ... stay happy and healthy is important regardless of the season, but even more so ...
(Date:9/3/2015)... COLO (PRWEB) , ... September 03, 2015 , ... Fashion ... the very beginning of the most recent episode of the hit ABC series ... didn’t fit the image of her industry. She provided herself with the motivation to ...
Breaking Medicine News(10 mins):Health News:Men Dissatisfied with the Primary Care Physician’s Approach to Andropause Are Turning to Renew Man™ 2Health News:Men Dissatisfied with the Primary Care Physician’s Approach to Andropause Are Turning to Renew Man™ 3Health News:Noted Santa Rosa Urologist Dr. Michael Lazar Provides Insights on Prostate Cancer Treatments in Recognition of Prostate Cancer Awareness Month 2Health News:Noted Santa Rosa Urologist Dr. Michael Lazar Provides Insights on Prostate Cancer Treatments in Recognition of Prostate Cancer Awareness Month 3Health News:James Earl Jones Hosts a New "Voices In America" Piece on Making the Workplace Healthier 2Health News:Doctor Kayode Sotonwa Highlights Expert Tips for Staying in Shape This Fall 2Health News:New “Extreme Weight Loss” Video Blog from the CU Anschutz Health and Wellness Center: Kim Begins with the End in Mind and Designs a Fashionable Future 2Health News:New “Extreme Weight Loss” Video Blog from the CU Anschutz Health and Wellness Center: Kim Begins with the End in Mind and Designs a Fashionable Future 3
... from living in two-parent families may actually be due to ... married. A new study finds that children who who ... do as well as those in married households in terms ... studies that show an advantage for children who grow up ...
... , , MONROE, Mich., ... center are joining forces to bring world-renowned cancer services to ... Health System of Toledo, and the Barbara Ann Karmanos Cancer ... will bring innovative, state-of-the-science cancer care to Monroe and the ...
... , Channels Extend Their Pledge for the ... , , LOS ANGELES and NEW YORK, Aug. 31 ... partnership with FC Barcelona and Malaria No More to end malaria deaths through ... campaign during Fox Football Fone-In, Fox Soccer Channel,s weekly call-in ...
... , WALTHAM, Mass., Aug. 31 ... dangerously hot weather conditions, Mobile Sports, Inc. (MSI) today announced ... athletes, parents of athletes, coaches, and athletic trainers the tools ... serious heat-related illnesses. , , ...
... Aug. 31 Mederi Therapeutics Inc. announces the US release ... Secca Therapy is a minimally invasive procedure for a debilitating ... both young and old. Secca therapy delivers radiofrequency (RF) energy ... muscles, producing better bowel control and reducing the symptoms of ...
... ... and Careers Division , ... York (PRWEB) August 31, 2009 -- The education and technology company Pearson today ... of its Professional & Career business., , , , ,Pearson,s Health Science and Careers division ...
Cached Medicine News:Health News:Family stability may be more crucial than 2 parents for child success 2Health News:Family stability may be more crucial than 2 parents for child success 3Health News:Three Health Institutions Join Forces to Bring World-Renowned Cancer Care to Monroe, Michigan 2Health News:Three Health Institutions Join Forces to Bring World-Renowned Cancer Care to Monroe, Michigan 3Health News:Three Health Institutions Join Forces to Bring World-Renowned Cancer Care to Monroe, Michigan 4Health News:Fox Soccer Channel and Fox Sports en Espanol Renew 'Every Goal Saves A Life' Campaign With Malaria No More 2Health News:Fox Soccer Channel and Fox Sports en Espanol Renew 'Every Goal Saves A Life' Campaign With Malaria No More 3Health News:Fox Soccer Channel and Fox Sports en Espanol Renew 'Every Goal Saves A Life' Campaign With Malaria No More 4Health News:New Technology Helps Athletes Prevent Dehydration and Heat-Related Illness 2Health News:Secca(R) Therapy - An Effective and Minimally Invasive Option for Treating Bowel Incontinence - Launched in the US 2Health News:Pearson Announces Leah Jewell as President of Health Science and Careers Division 2Health News:Pearson Announces Leah Jewell as President of Health Science and Careers Division 3
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: